{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:58:26Z","timestamp":1762876706524,"version":"3.45.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Key research and development project under the National Key R&D Program's \"Frontier Biotechnology\" special initiative","award":["2023YFC3404000"],"award-info":[{"award-number":["2023YFC3404000"]}]},{"name":"Liaoning biological pharmaceutical animal cell culture engineering technology research center."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Biol Eng"],"DOI":"10.1186\/s13036-025-00576-y","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:52:40Z","timestamp":1762872760000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thrombomodulin is essential for recombinant Fc-fusion protein production in Chinese hamster ovary cells via multiple signaling pathways"],"prefix":"10.1186","volume":"19","author":[{"given":"Xiaonan","family":"Ma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nawei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qihang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guorong","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lunxiao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruoyin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ningning","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"issue":"11","key":"576_CR1","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1038\/nbt1026","volume":"22","author":"FM Wurm","year":"2004","unstructured":"Wurm FM. Production of Recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol. 2004;22(11):1393\u20138.","journal-title":"Nat Biotechnol"},{"key":"576_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jbiotec.2016.03.054","volume":"227","author":"C Kaisermayer","year":"2016","unstructured":"Kaisermayer C, Reinhart D, Gili A, Chang M, Aberg PM, Castan A, et al. Biphasic cultivation strategy to avoid Epo-Fc aggregation and optimize protein expression. J Biotechnol. 2016;227:3\u20139.","journal-title":"J Biotechnol"},{"key":"576_CR3","doi-asserted-by":"crossref","unstructured":"McHugh KP, Xu J. Effective temperature shift strategy development and scale confirmation for simultaneous optimization of protein productivity and quality in Chinese hamster ovary cells. Biotechnol Prog. 2020;36(3):e2959.","DOI":"10.1002\/btpr.2959"},{"key":"576_CR4","doi-asserted-by":"crossref","unstructured":"Weng Z, Jin J, Shao C, Li H. Reduction of charge variants by CHO cell culture process optimization. Cytotechnology. 2020;72(2):259\u201369.","DOI":"10.1007\/s10616-020-00375-x"},{"key":"576_CR5","doi-asserted-by":"publisher","first-page":"102806","DOI":"10.1016\/j.copbio.2022.102806","volume":"78","author":"J Donaldson","year":"2022","unstructured":"Donaldson J, Kleinjan DJ, Rosser S. Synthetic biology approaches for dynamic CHO cell engineering. Curr Opin Biotechnol. 2022;78:102806.","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"576_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1002\/biot.201100369","volume":"7","author":"S Dietmair","year":"2012","unstructured":"Dietmair S, Nielsen LK, Timmins NE. Mammalian cells as biopharmaceutical production hosts in the age of omics. Biotechnol J. 2012;7(1):75\u201389.","journal-title":"Biotechnol J"},{"issue":"3","key":"576_CR7","doi-asserted-by":"publisher","first-page":"e1700227","DOI":"10.1002\/biot.201700227","volume":"13","author":"G Stolfa","year":"2018","unstructured":"Stolfa G, Smonskey MT, Boniface R, Hachmann AB, Gulde P, Joshi AD, et al. CHO-Omics review: the impact of current and emerging technologies on Chinese hamster ovary based bioproduction. Biotechnol J. 2018;13(3):e1700227.","journal-title":"Biotechnol J"},{"issue":"8","key":"576_CR8","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.biotechadv.2015.10.015","volume":"33","author":"S Fischer","year":"2015","unstructured":"Fischer S, Handrick R, Otte K. The Art of CHO cell engineering: A comprehensive retrospect and future perspectives. Biotechnol Adv. 2015;33(8):1878\u201396.","journal-title":"Biotechnol Adv"},{"issue":"8","key":"576_CR9","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1007\/s00449-020-02332-6","volume":"43","author":"H Fouladiha","year":"2020","unstructured":"Fouladiha H, Marashi SA, Torkashvand F, Mahboudi F, Lewis NE, Vaziri B. A metabolic network-based approach for developing feeding strategies for CHO cells to increase monoclonal antibody production. Bioprocess Biosyst Eng. 2020;43(8):1381\u20139.","journal-title":"Bioprocess Biosyst Eng"},{"key":"576_CR10","doi-asserted-by":"crossref","unstructured":"Yao G, Aron K, Borys M, Li Z. A metabolomics approach to increasing Chinese hamster ovary (CHO). Cell Productivity. 2021;11(12).","DOI":"10.3390\/metabo11120823"},{"key":"576_CR11","doi-asserted-by":"publisher","first-page":"856049","DOI":"10.3389\/fbioe.2022.856049","volume":"10","author":"JH Zhang","year":"2022","unstructured":"Zhang JH, Shan LL, Liang F, Du CY, Li JJ. Strategies and considerations for improving Recombinant antibody production and quality in Chinese hamster ovary cells. Front Bioeng Biotechnol. 2022;10:856049.","journal-title":"Front Bioeng Biotechnol"},{"issue":"20","key":"576_CR12","doi-asserted-by":"publisher","first-page":"15312","DOI":"10.1016\/S0021-9258(18)82471-1","volume":"268","author":"SR Lentz","year":"1993","unstructured":"Lentz SR, Chen Y, Sadler JE. Sequences required for thrombomodulin cofactor activity within the fourth epidermal growth factor-like domain of human thrombomodulin. J Biol Chem. 1993;268(20):15312\u20137.","journal-title":"J Biol Chem"},{"issue":"2","key":"576_CR13","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood-2017-12-768994","volume":"132","author":"H Loghmani","year":"2018","unstructured":"Loghmani H, Conway EM. Exploring traditional and nontraditional roles for thrombomodulin. Blood. 2018;132(2):148\u201358.","journal-title":"Blood"},{"issue":"2","key":"576_CR14","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1182\/blood.V75.2.329.329","volume":"75","author":"WA Dittman","year":"1990","unstructured":"Dittman WA, Majerus PW. Structure and function of thrombomodulin: a natural anticoagulant. Blood. 1990;75(2):329\u201336.","journal-title":"Blood"},{"issue":"5","key":"576_CR15","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/em.21937","volume":"56","author":"AY Efremenko","year":"2015","unstructured":"Efremenko AY, Seagrave J, Clewell HJ, Van Landingham C, Gentry PR, Yager JW. Evaluation of gene expression changes in human primary lung epithelial cells following 24-hr exposures to inorganic arsenic and its methylated metabolites and to arsenic trioxide. Environ Mol Mutagen. 2015;56(5):477\u201390.","journal-title":"Environ Mol Mutagen"},{"issue":"3","key":"576_CR16","doi-asserted-by":"publisher","first-page":"e0122491","DOI":"10.1371\/journal.pone.0122491","volume":"10","author":"YH Huang","year":"2015","unstructured":"Huang YH, I CC, Kuo CH, Hsu YY, Lee FT, Shi GY, et al. Thrombomodulin promotes corneal epithelial wound healing. PLoS ONE. 2015;10(3):e0122491.","journal-title":"PLoS ONE"},{"issue":"8","key":"576_CR17","doi-asserted-by":"publisher","first-page":"e72392","DOI":"10.1371\/journal.pone.0072392","volume":"8","author":"M Toda","year":"2013","unstructured":"Toda M, Shao Z, Yamaguchi KD, Takagi T, D\u2019Alessandro-Gabazza CN, Taguchi O, et al. Differential gene expression in thrombomodulin (TM; CD141)(+) and TM(-) dendritic cell subsets. PLoS ONE. 2013;8(8):e72392.","journal-title":"PLoS ONE"},{"issue":"4","key":"576_CR18","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1161\/ATVBAHA.115.306780","volume":"36","author":"RJ Turner","year":"2016","unstructured":"Turner RJ, Bloemenkamp KW, Bruijn JA, Baelde HJ. Loss of thrombomodulin in placental dysfunction in preeclampsia. Arterioscler Thromb Vasc Biol. 2016;36(4):728\u201335.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"576_CR19","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1177\/1535370220914058","volume":"245","author":"X Ma","year":"2020","unstructured":"Ma X, Zhang L, Zhang L, Wang C, Guo X, Yang Y, et al. Validation and identification of reference genes in Chinese hamster ovary cells for Fc-fusion protein production. Experimental Biology Med. 2020;245(8):690\u2013702.","journal-title":"Experimental Biology Med"},{"issue":"4","key":"576_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA, Hellemans J, Huggett J, Kubista M, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611\u201322.","journal-title":"Clin Chem"},{"issue":"6","key":"576_CR21","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.str.2023.04.005","volume":"31","author":"H Woods","year":"2023","unstructured":"Woods H, Schiano DL, Aguirre JI, Ledwitch KV, McDonald EF, Voehler M, et al. Computational modeling and prediction of deletion mutants. Structure. 2023;31(6):713\u2013e233.","journal-title":"Structure"},{"issue":"Pt 2","key":"576_CR22","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1042\/bj3320281","volume":"332","author":"H Mellor","year":"1998","unstructured":"Mellor H, Parker PJ. The extended protein kinase C superfamily. Biochem J. 1998;332(Pt 2):281\u201392.","journal-title":"Biochem J"},{"issue":"6","key":"576_CR23","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s10741-017-9634-3","volume":"22","author":"RM Singh","year":"2017","unstructured":"Singh RM, Cummings E, Pantos C, Singh J. Protein kinase C and cardiac dysfunction: a review. Heart Fail Rev. 2017;22(6):843\u201359.","journal-title":"Heart Fail Rev"},{"key":"576_CR24","doi-asserted-by":"publisher","first-page":"1010092","DOI":"10.3389\/fendo.2022.1010092","volume":"13","author":"J Scerri","year":"2022","unstructured":"Scerri J, Scerri C, Sch\u00e4fer-Ruoff F, Fink S, Templin M, Grech G. PKC-mediated phosphorylation and activation of the MEK\/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer. Front Endocrinol. 2022;13:1010092.","journal-title":"Front Endocrinol"},{"issue":"1","key":"576_CR25","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.molcel.2015.01.023","volume":"58","author":"K Ichikawa","year":"2015","unstructured":"Ichikawa K, Kubota Y, Nakamura T, Weng JS, Tomida T, Saito H, et al. MCRIP1, an ERK substrate, mediates ERK-induced gene Silencing during epithelial-mesenchymal transition by regulating the co-repressor CtBP. Mol Cell. 2015;58(1):35\u201346.","journal-title":"Mol Cell"},{"issue":"2","key":"576_CR26","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1038\/ncb1676","volume":"10","author":"JY Yang","year":"2008","unstructured":"Yang JY, Zong CS, Xia W, Yamaguchi H, Ding Q, Xie X, et al. ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation. Nat Cell Biol. 2008;10(2):138\u201348.","journal-title":"Nat Cell Biol"},{"issue":"12","key":"576_CR27","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.1038\/s41401-018-0079-6","volume":"39","author":"HW Yang","year":"2018","unstructured":"Yang HW, Hong HL, Luo WW, Dai CM, Chen XY, Wang LP, et al. mTORC2 facilitates endothelial cell senescence by suppressing Nrf2 expression via the Akt\/GSK-3\u03b2\/C\/EBP\u03b1 signaling pathway. Acta Pharmacol Sin. 2018;39(12):1837\u201346.","journal-title":"Acta Pharmacol Sin"},{"issue":"1","key":"576_CR28","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1465-9921-15-26","volume":"15","author":"EY Kim","year":"2014","unstructured":"Kim EY, Kim A, Kim SK, Kim HJ, Chang J, Ahn CM, et al. Inhibition of mTORC1 induces loss of E-cadherin through AKT\/GSK-3\u03b2 signaling-mediated upregulation of E-cadherin repressor complexes in non-small cell lung cancer cells. Respir Res. 2014;15(1):26.","journal-title":"Respir Res"},{"issue":"11","key":"576_CR29","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.3724\/abbs.2022159","volume":"54","author":"L Wan","year":"2022","unstructured":"Wan L, Wang Y, Li J, Wang Y, Zhang H. Inhibition of the AKT\/mTOR pathway negatively regulates PTEN expression via MiRNAs. Acta Biochim Biophys Sin. 2022;54(11):1637\u201347.","journal-title":"Acta Biochim Biophys Sin"},{"issue":"16","key":"576_CR30","doi-asserted-by":"publisher","first-page":"13962","DOI":"10.18632\/oncotarget.3920","volume":"6","author":"W Mi","year":"2015","unstructured":"Mi W, Ye Q, Liu S, She QB. AKT Inhibition overcomes Rapamycin resistance by enhancing the repressive function of PRAS40 on mTORC1\/4E-BP1 axis. Oncotarget. 2015;6(16):13962\u201377.","journal-title":"Oncotarget"},{"key":"576_CR31","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1146\/annurev.physiol.60.1.575","volume":"60","author":"EB Thompson","year":"1998","unstructured":"Thompson EB. The many roles of c-Myc in apoptosis. Annu Rev Physiol. 1998;60:575\u2013600.","journal-title":"Annu Rev Physiol"},{"key":"576_CR32","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.semcancer.2020.11.008","volume":"83","author":"H Fatma","year":"2022","unstructured":"Fatma H, Maurya SK, Siddique HR. Epigenetic modifications of c-MYC: role in cancer cell reprogramming, progression and chemoresistance. Sem Cancer Biol. 2022;83:166\u201376.","journal-title":"Sem Cancer Biol"},{"key":"576_CR33","doi-asserted-by":"publisher","first-page":"587218","DOI":"10.3389\/fcell.2021.587218","volume":"9","author":"L Bai","year":"2021","unstructured":"Bai L, Ma Y, Wang X, Feng Q, Zhang Z, Wang S, et al. Polydatin inhibits cell Viability, Migration, and invasion through suppressing the c-Myc expression in human cervical cancer. Front Cell Dev Biology. 2021;9:587218.","journal-title":"Front Cell Dev Biology"},{"issue":"1","key":"576_CR34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/s41420-021-00622-w","volume":"8","author":"Z Li","year":"2022","unstructured":"Li Z, Zhang L, Liu D, Yang Z, Xuan D, Zhang Y. Knockdown of NRMT enhances sensitivity of retinoblastoma cells to cisplatin through upregulation of the CENPA\/Myc\/Bcl2 axis. Cell Death Discovery. 2022;8(1):14.","journal-title":"Cell Death Discovery"},{"issue":"10","key":"576_CR35","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s10495-010-0515-7","volume":"15","author":"J Skommer","year":"2010","unstructured":"Skommer J, Brittain T, Raychaudhuri S. Bcl-2 inhibits apoptosis by increasing the time-to-death and intrinsic cell-to-cell variations in the mitochondrial pathway of cell death. Apoptosis: Int J Program Cell Death. 2010;15(10):1223\u201333.","journal-title":"Apoptosis: Int J Program Cell Death"},{"issue":"7","key":"576_CR36","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1172\/JCI925","volume":"101","author":"Y Zhang","year":"1998","unstructured":"Zhang Y, Weiler-Guettler H, Chen J, Wilhelm O, Deng Y, Qiu F, et al. Thrombomodulin modulates growth of tumor cells independent of its anticoagulant activity. J Clin Investig. 1998;101(7):1301\u20139.","journal-title":"J Clin Investig"},{"issue":"5","key":"576_CR37","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.biotechadv.2011.08.022","volume":"30","author":"J Zhu","year":"2012","unstructured":"Zhu J. Mammalian cell protein expression for biopharmaceutical production. Biotechnol Adv. 2012;30(5):1158\u201370.","journal-title":"Biotechnol Adv"},{"issue":"4","key":"576_CR38","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/bit.21222","volume":"97","author":"B Figueroa Jr","year":"2007","unstructured":"Figueroa B Jr., Ailor E, Osborne D, Hardwick JM, Reff M, Betenbaugh MJ. Enhanced cell culture performance using inducible anti-apoptotic genes E1B-19K and aven in the production of a monoclonal antibody with Chinese hamster ovary cells. Biotechnol Bioeng. 2007;97(4):877\u201392.","journal-title":"Biotechnol Bioeng"},{"issue":"100","key":"576_CR39","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ymben.2014.05.011","volume":"24","author":"J Nocon","year":"2014","unstructured":"Nocon J, Steiger MG, Pfeffer M, Sohn SB, Kim TY, Maurer M, et al. Model based engineering of Pichia pastoris central metabolism enhances Recombinant protein production. Metab Eng. 2014;24(100):129\u201338.","journal-title":"Metab Eng"},{"issue":"2","key":"576_CR40","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.ijcard.2014.01.009","volume":"172","author":"TH Chao","year":"2014","unstructured":"Chao TH, Tsai WC, Chen JY, Liu PY, Chung HC, Tseng SY, et al. Soluble thrombomodulin is a paracrine anti-apoptotic factor for vascular endothelial protection. Int J Cardiol. 2014;172(2):340\u20139.","journal-title":"Int J Cardiol"},{"issue":"4","key":"576_CR41","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.jtha.2024.01.006","volume":"22","author":"H Giri","year":"2024","unstructured":"Giri H, Biswas I, Rezaie AR. Thrombomodulin: a multifunctional receptor modulating the endothelial quiescence. J Thromb Haemostasis: JTH. 2024;22(4):905\u201314.","journal-title":"J Thromb Haemostasis: JTH"}],"container-title":["Journal of Biological Engineering"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-025-00576-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13036-025-00576-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13036-025-00576-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:52:43Z","timestamp":1762872763000},"score":1,"resource":{"primary":{"URL":"https:\/\/jbioleng.biomedcentral.com\/articles\/10.1186\/s13036-025-00576-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["576"],"URL":"https:\/\/doi.org\/10.1186\/s13036-025-00576-y","relation":{},"ISSN":["1754-1611"],"issn-type":[{"value":"1754-1611","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"99"}}